고위험 인자 또는 우려 인자를 가진 췌관 내 유두상 점액성 종양: 내과의사의 입장
(주)코리아스칼라
- 최초 등록일
- 2023.04.03
- 최종 저작일
- 2023.01
- 8페이지/ 어도비 PDF
- 가격 4,000원
* 본 문서는 배포용으로 복사 및 편집이 불가합니다.
서지정보
ㆍ발행기관 : 대한췌담도학회
ㆍ수록지정보 : 대한췌담도학회지 / 28권 / 1호
ㆍ저자명 : 전형구, 김태현
목차
서 론
본 론
1. 췌장 IPMN의 진료지침
2. High risk stigmata와 worrisome feature의 추가적평가
3. 악성 위험 인자들의 악성도 차이와 역동적 변화의 중요성
4. 주췌관 침범 IPMN의 치료 전략
결 론
요 약
ORCID
REFERENCES
영어 초록
There are still debated about surveillance interval, duration, diagnostic modality and treatment for intraductal papillary mucinous neoplasm (IPMN) of the pancreas. In recent guidelines, ‘high risk stigmata (HRS)’ and ‘worrisome feature (WF)’ are defined as predictive factors for malignancy in IPMN. IPMNs with HRS and main duct- IPMN are more likely to accompany malignancies, thus require surgery. However, in the case of only WF, since the risk of malignancy is different for each factor, the management decision can be variable according to the number of overlapping WFs. In addition, for segmental main pancreatic duct dilatation without enhancing mural nodules, careful surveillance might be considered rather than immediate surgery. In IPMN patients with elderly or severe comorbidities, treatment strategy should be determined based on surgical and malignant risk assessment. To date, the natural course of IPMN patients with HRS and WF is not well understood, thus further studies with a large number of patients are needed.
참고 자료
없음